Literature DB >> 16855059

Thrombolytic therapy for massive pulmonary embolism in a patient with a known intracranial tumor.

Steve Han1, Craig Chaya, Guy W Soo Hoo.   

Abstract

The objective was to describe and review the use of thrombolytic therapy in a patient with an intracranial tumor and massive pulmonary embolism. This is the first reported case of a patient with a known glioblastoma multiforme and massive pulmonary embolism who was successfully treated with alteplase. Pulmonary embolism was demonstrated by a ventilation-perfusion scan and transthoracic echocardiogram with repeat studies demonstrating resolution of the thromboembolism and reperfusion of pulmonary vasculature. A review of the literature revealed that the incidence of intracranial hemorrhage with thrombolysis is <3% and compares favorably with the much higher mortality rate of 25% to >/=50% in patients with hemodynamically unstable pulmonary emboli. The benefit of thrombolysis may outweigh the risks of intracranial hemorrhage in these patients, and careful consideration for its use in these patients is warranted.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16855059     DOI: 10.1177/0885066606287047

Source DB:  PubMed          Journal:  J Intensive Care Med        ISSN: 0885-0666            Impact factor:   3.510


  9 in total

1.  Thrombolysis for ischaemic stroke and glioblastoma multiforme: a case report.

Authors:  Ana M Garcia; Jose A Egido; Maria E Garcia; Patricia Simal
Journal:  BMJ Case Rep       Date:  2009-02-23

2.  Fibrinolytic Enzyme Cotherapy Improves Tumor Perfusion and Therapeutic Efficacy of Anticancer Nanomedicine.

Authors:  Ameya R Kirtane; Tanmoy Sadhukha; Hyunjoon Kim; Vidhi Khanna; Brenda Koniar; Jayanth Panyam
Journal:  Cancer Res       Date:  2017-01-20       Impact factor: 12.701

3.  Atrial flutter in a patient with glioblastoma multiforme: problems in treating thromboembolic complications.

Authors:  Alexander Liu; Pawan Pusalkar
Journal:  BMJ Case Rep       Date:  2011-06-29

4.  All contraindications to thrombolysis for life-threatening pulmonary embolus should be considered relative.

Authors:  Rachel M Mercer; Jordan S T Bowen; Richard J Armstrong
Journal:  BMJ Case Rep       Date:  2013-12-10

5.  Life-saving systemic thrombolysis in a patient with massive pulmonary embolism and a recent hemorrhagic cerebrovascular accident.

Authors:  Wendy Bottinor; Jeremy Turlington; Syed Raza; Charlotte S Roberts; Rajiv Malhotra; Ion S Jovin; Antonio Abbate
Journal:  Tex Heart Inst J       Date:  2014-04-01

Review 6.  Absolute and Relative Contraindications to IV rt-PA for Acute Ischemic Stroke.

Authors:  Jennifer E Fugate; Alejandro A Rabinstein
Journal:  Neurohospitalist       Date:  2015-07

7.  Systemic thrombolysis in a patient with massive pulmonary embolism and recent glioblastoma multiforme resection.

Authors:  Joshua Lampert; Behnood Bikdeli; Philip Green; Matthew R Baldwin
Journal:  BMJ Case Rep       Date:  2017-11-29

8.  Emergent pulmonary embolectomy and advanced glioblastoma multiforme.

Authors:  Michael S Firstenberg; Danielle Blais; Erik Abel; Herbert B Newton; Juan Crestanello
Journal:  Case Rep Med       Date:  2010-12-20

9.  Off-label use of IV t-PA in patients with intracranial neoplasm and cavernoma.

Authors:  Christopher Jan Schwarzbach; Anne Ebert; Michael G Hennerici; Eva Neumaier-Probst; Michael Platten; Marc Fatar
Journal:  Ther Adv Neurol Disord       Date:  2018-02-05       Impact factor: 6.570

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.